Developmental in Biological Technology

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

... Pirag distinguished professor in Pediatric developmental Cardiology at UCSF. Dr. Srivastava's research ... heart disease and on using knowledge of cardiac developmental pathways to devise novel therapeutics for human ... at Harvard University . A world authority in developmental biology, pancreatic development, and metabolic ...

Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting

... - Abstract No: 3055 Poster session: developmental Therapeutics: Immunotherapy - Saturday ... - Abstract No: 3542 Poster session: developmental Therapeutics: Molecular Therapeutics - ... - Abstract # 2571, Poster Session: developmental Therapeutics: Cytotoxic Chemotherapy - ...

Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting

... May 30, 2009 at 5:00 p.m. ET Track: developmental Therapeutics Session: developmental Therapeutics: Molecular Therapeutics ... Monday, June 1, 2009 at 3:45 p.m. ET Track: developmental Therapeutics, Lymphoma and Plasma Cell Disorders ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

... treated with ipilimumab" (Abstract #9008, developmental Therapeutics: Immunotherapy Session) O. Hamid - ... treated with ipilimumab" (Abstract #3031, developmental Therapeutics: Immunotherapy Session) S. Parker - ... treated with ipilimumab" (Abstract #3020, developmental Therapeutics: Immunotherapy Session) D. Berman - ...

Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team

... ALS, heart failure, stroke and paralysis; developmental disorders including Down syndrome; and metastatic ... natural products to manipulate activities of developmental and stem cell signaling pathways in vitro and in ... ALS, heart failure, stroke and paralysis; developmental disorders including Down syndrome; and metastatic ...

Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies

... application across all degenerative diseases, developmental disorders and cancers, and in enabling the ... natural products to manipulate activities of developmental and stem cell signaling pathways in vitro and in ... hope in the treatment of degenerative diseases, developmental disorders, and cancer and in enabling the ...

Mice teeth explain the troubles with human wisdom teeth

... time scientists have suspected that genetic and developmental interactions may also influence species-specific ... the evolution of teeth, and have devised a simple developmental model to predict aspects of teeth across many ... In the study in the field of evolutionary developmental biology, the researchers Kathryn Kavanagh, Jukka ...

Microfluidic chambers advance the science of growing neurons

... author on the study and the head of the cell and developmental biology department at Illinois. This is pushing ... the material used to form the chambers. Cell and developmental biology graduate student Larry Millet exposed the ... Gillette is Alumni Professor of Cell and developmental Biology. All are appointed in the Institute for ...

It's a Bug's Life, as Flawless Photo of Wasp Wins Worldwide Olympus BioScapes Competition : Winning Sure Doesn't Sting - Olympus BioScapes 2008 Competition

... dedicated researchers study neurological disorders, cancer, plant science, developmental biology and much more." Other images recognized in this ... M. Murray, M.D., Ph.D., Associate Professor in the Department of Cell and developmental Biology at the University of Pennsylvania Medical School in Philadelphia; ...

New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture

... A recently published study in the scientific journal In Vitro Cellular & developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see ... from rice, stimulates mammalian cell growth. In Vitro Cellular & developmental Biology. September 19, 2008 (E-publication Date). ...

$1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope

... X Foundation (NFXF), the CDC's National Center on Birth Defects and developmental Disabilities, the Association of University Centers on Disabilities, the New York State Institute for Basic Research in developmental Disabilities and the Data Coordinating Center at Columbia University. ...

REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO

... solid malignancies (ASM)" Day: Saturday, May 31 Session: developmental Therapeutics: Molecular Therapeutics Time (Poster): 8 a.m.-noon ... medullary thyroid cancer (MTC)" Day: Sunday, June 1 Session: developmental Therapeutics: Molecular Therapeutics Time: 10-10:15 a.m. Location: ...

Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing

... malignancies (ASM)" Day: Saturday, May 31 Session: developmental Therapeutics: Molecular Therapeutics Time (Poster): 8 a.m.-noon ... medullary thyroid cancer (MTC)" Day: Sunday, June 1 Session: developmental Therapeutics: Molecular Therapeutics Time: 10-10:15 a.m. ...

March of Dimes Awards $250,000 Prize to Leaders in Understanding Embryonic Development

... Dr. Beachy is the Ernest and Amelia Gallo Professor in the Department of developmental Biology and in the Institute for Stem Cell Biology and Regenerative ... proper orientation in the forming limbs. The March of Dimes Prize in developmental Biology has been awarded annually since 1996 to investigators whose ...

Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.

... research in cardiac and vascular disease, cancer, stem cell research and developmental biology. "VisualSonics has an expansive business strategy that builds on ... research in cardiac and vascular disease, cancer, stem cell research and developmental biology. When compared to other imaging options, only micro-ultrasound has ...

D-Pharm Completes Pre-IND Meeting With the FDA for Treatment of Acute Stroke With DP-b99

... from the FDA is most encouraging. With a number of uncertainties in the developmental program removed we may now follow a clear path towards an IND application ... Other mimics of bioactive lipids, LipidoMimetix, are at an earlier developmental stage, for cancer. For further information please contact: Tami ...

New Director of Lab Sales for Polymathic Analytical Labs

... a Zeus company, is located in Orangeburg, South Carolina USA. Polymathic Analytical Labs is an unbiased resource, providing confidential research and developmental support to a wide array of markets through sophisticated and extensive materials testing, identification, technical problem solving and analysis. ...

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

... to a stem cell state through the insertion of four genes. iPS cells are similar to human embryonic stem (hES) cells in their proliferative and developmental potential, but they avoid the controversial and ethical concerns surrounding hES cells. Considered a significant scientific breakthrough, iPS cells ...

Karl Strauss and GreenHouse Partner to Create Alternative Fuel from Beer Waste

... E-Fuel MicroFuelerTM, a portable ethanol micro-refinery fuel system for consumer use. Together, the two companies are part of the GreenHouse developmental Pilot Program, a distribution model being introduced first in Southern California. Within the agreement, award-winning Karl Strauss Brewing Company ...

Canadian researchers discover gene related to the appearance of aging

... a rare disorder known as cutis laxa type 2 (CL2), which causes skin on the hands, feet and face to be loose and older looking, as well as growth and developmental delays including effects on the brain. In the process, researchers found some interesting correlations with the synthesis of proline, a chemical ...

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies

... or develop new antibodies for potential therapeutic applications. About Cancer Innovations, Inc. Cancer Innovations, Inc. is a developmental stage biotechnology company dedicated to the discovery, development and commercialization of novel biopharmaceutical therapeutics, diagnostics as ...

Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia

... Inc. in February 2008. About CrystalGenomics: CrystalGenomics, Inc. is a novel drug discovery and development company with several developmental candidates in the areas of cancer, inflammation and novel antibiotics. The lead candidate, CG100649 is a next generation NSAID with high safety and ...

Scientists identify gene vital to early embryonic cells forming a normal heart and skull

... National Academy of Sciences , a research team at Cincinnati Children's reports that too little of the gene/protein SHP2 interferes with the normal developmental activity of what are called neural crest cells. These cells, which occur very early in embryonic development, migrate to specific regions of the ...

D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients

... intended as an oral, disease-modifying therapy for Alzheimer's disease. Other mimics of bioactive lipids, LipidoMimetix, are at an earlier developmental stage, for cancer. For further information please contact: Tami Horovitz, PhD. Tel: +972-8-9385100 Fax: +972-8-9300795 ...

Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research

... with high quality phenotype data," Johnson said. The SFARI mission is to improve the diagnosis, treatment, and prevention of autism and related developmental disorders. The SFARI database, known as SFARI Base, is a new resource for autism research that provides the scientific community access to genetic ...

Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

... NY; TGen Clinical Research Services, Scottsdale, AZ; Mersana Therapeutics, Inc., Cambridge, MA; Covance Bioanalytical, Madison, WI Session: developmental Therapeutics: Cytotoxic Chemotherapy Type: General Poster Session Time: Saturday May 30, 2009, 8:00 AM to 12:00 PM Location: Level 2, ...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

... et al. AT-101 or placebo (P) with docetaxel (D) in second line NSCLC with gene signature biomarker development. Abstract #3577; Poster Board #J19; developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m. Heist R, et al. A phase I/II study of AT-101 in combination with topotecan (T) in patients with ...

MIT, BU engineer cellular circuits that count events

... Such circuits, which mimic those found on computer chips, could be used to count the number of times a cell divides, or to study a sequence of developmental stages. They could also serve as biosensors that count exposures to different toxins. The team developed two types of cellular counters, both ...

Professor Wing Wong Elected to the National Academy of Sciences

... and include methods and algorithms for the analysis of gene expression data from microarray chips, identification of gene regulatory elements in developmental genomics, and elucidation of genetic networks. According to Professor Paul Schimmel, co-founder of aTyr Pharma and fellow NAS member: "We are ...

Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Children's Hospital Boston and Massachusetts General Hospital

... of the major specialized cell types of the particular tissue or organ in which it is found. The discovery of a number of conserved mechanisms from developmental biology and tissue repair has led to the identification of small molecules and biologics that can direct stem cell proliferation and function. Fate ...

Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine

... all disorders detected by traditional cytogenetics and fluorescent in situ hybridization (FISH). Array CGH is designed for patients with unexplained developmental delay, autism spectrum disorders, dysmorphic features, unexplained mental retardation, and/or multiple congenital anomalies. Each array contains 105K ...

Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening

... has a core staff of about 400 scientists, which form a network of 27 research groups covering different topics at the interface of cell biology and developmental biology including research investigating illnesses such as cancer or Alzheimer's disease. For example, at the MPI-CBG researchers study how the ...

AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies

... is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to ...

Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009

... Center for Children in Austin, Texas. Aaron's Bridge was created to facilitate access to more treatment options in Oklahoma for children with developmental disabilities, including autism spectrum disorder. "We formed the foundation to build a bridge of hope, connecting Oklahoma families to ...

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

... NOVABAY PHARMACEUTICALS, INC (formerly NovaCal Pharmaceuticals Inc.) (a developmental stage company) CONSOLIDATED BALANCE SHEETS (in thousands, except per share data) ...

Codexis Names Lori Giver VP Systems Biology

... She received a bachelor's degree in molecular and cell biology from the University of California at Berkeley , and a Ph.D. in molecular, cell and developmental biology from Indiana University, Bloomington , where she focused on the directed evolution of nucleic acids with Dr. Andrew Ellington. Dr. Giver ...

VisualSonics to Sell Mauna Kea Technologies' Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market

... world's most prestigious pharmaceutical and biotechnology companies, hospitals and universities to conduct research in cardiovascular, cancer, and developmental biology areas. The technology supports applications that include genetic research, phenotypic studies and drug development. VisualSonics platforms ...

InNexus Biotechnology Announces a Loan Facility of up to USD$2.5 Million

... is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to ...

WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research

... of samples taken over the course of the healing response promises to provide us with unique insights into the healing process and the role our developmental candidate plays in enhancing the rate at which wounds heal." "This collaboration places UT Southwestern in the enviable position of evaluating ...

InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies

... is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to ...